ASRT
Assertio Holdings, Inc.
Key Financials
Revenue
$118.7M
↓ 5.0%
Net Income
$-30375000
↓ 40.7%
EPS (Diluted)
$-4.74
↓ 1960.9%
Total Assets
$267.0M
↓ 6.2%
Cash & Equivalents
$10.2M
↓ 79.8%
Shareholders' Equity
$94.0M
↓ 22.4%
Total Liabilities
$173.0M
↑ 5.7%
Operating Income
$-21536000
↑ 12.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 6/26/2026 | View on SEC |
| EFFECT | 6/17/2026 | View on SEC |
| EFFECT | 6/17/2026 | View on SEC |
| EFFECT | 6/17/2026 | View on SEC |
| EFFECT | 6/17/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ASRT |
| Company Name | Assertio Holdings, Inc. |
| CIK | 1808665 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (224) 419-7106 |